CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 8-K Event Regulation FD disclosure · Other events
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Global Commercial Ops sold 9,558 shares at $262.43 ($2,508,306)
- 4 Grant or award Director acquired 153.37 shares (grant or award)
- 4 Grant or award Director acquired 124.62 shares (grant or award)
- 4 Grant or award Director acquired 124.62 shares (grant or award)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 4 Shares withheld for taxes SVP & CCO gave up 1,129 shares (to pay taxes)
- 11-K Other Annual Report
- 11-K Other Annual Report
- 8-K Event Other events
- 4 Grant or award Director acquired 939 shares (grant or award)
- 4 Grant or award Director acquired 939 shares (grant or award)
- 4 Grant or award Director acquired 939 shares (grant or award)
- 4 Grant or award Director acquired 939 shares (grant or award)
- 4 Grant or award Director acquired 939 shares (grant or award)
- 4 Grant or award Director acquired 939 shares (grant or award)
Page 20 of 161 · 3,201 filings